DAVID GRANOVSKY

Heart study finds long-term value in stem cell treatments – FierceBiotech Research

In STEM CELLS IN THE NEWS on September 22, 2010 at 8:17 pm

Heart study finds long-term value in stem cell treatments

August 31, 2010 — 8:10am ET | By John Carroll

Related Stories

* Adult stem cells key to ventricle transplants

* Osiris reports major gains in stem cell trial

* Heart researchers hunt for drugs that rein in mystery protein

* Researchers combat aging as a “stem cell disease”

* iPSC use may be limited by ‘memory’

* Artificial artery readied for human trials

* Stem cell patch developed to repair damaged hearts

* Cell discovery opens new door to heart researchers

* Revolutionary stem cell trials planned in the UK

* Researchers testing stem cell therapy for CHF

German scientists have posted some of the most convincing long-term data yet seen demonstrating that injections of a chronic heart failure patient’s own bone marrow stem cells can significantly improve heart function and raise their chances of survival.

The researchers recruited close to 400 subjects for the trial, nearly evenly dividing them between a group that received stem cell injections and another group which opted to go without the added therapy. Researchers said they could begin tracking a positive response after three months and found that after five years only seven of the stem cell treatment group had died compared to 32 in the control arm of the study. All of the patients were provided standard therapy for their condition.

“Our study suggests that, when administered as an alternative or in addition to conventional therapy, bone marrow cell therapy can improve quality of life, increase ventricular performance and increase survival,” said lead researcher Bodo-Eckehard Strauer of Duesseldorf’s Heinrich Heine University. And Strauer went on to tell a gathering in Stockholm that the therapy presents no risks and “can only be beneficial.”

Not everyone who has reviewed the data, though, is so certain. “God gave us two gifts for doing clinical research–blinding and randomization,” Rob Califf, vice chancellor for research at Duke University, told MedPage Today. “If you have done neither, your data are interesting but not definitive.”

via Heart study finds long-term value in stem cell treatments – FierceBiotech Research.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: